Matrix metalloproteinase
Matrix metalloproteinases are a family of zinc-containing endopeptidases capable of degrading virtually all components of the extracellular matrix (ECM). They are not inherently pathological – controlled MMP activity is essential for normal ECM remodelling, wound healing, and tissue development. The problem in ageing and photodamaged skin is not that MMPs exist but that their activity becomes chronically elevated relative to the endogenous inhibitors that should regulate them, shifting remodelling from a balanced maintenance process to progressive net structural loss. [9] Every structural entity in this knowledge base – Collagen, Elastin, Fibroblast, Dermis, Papillary Dermis, Reticular Dermis – describes the consequences of unregulated MMP activity. This entity describes the enzymes themselves.
Classification by Substrate
MMPs are grouped by their primary substrate specificity, which matters clinically because different presentations involve different MMP subtypes and respond to different interventions. [5]
Collagenases (MMP-1, MMP-8, MMP-13) cleave intact fibrillar collagen Types I and III at a single specific site within the triple helix, generating 3/4 and 1/4 length fragments. This initial cleavage is the rate-limiting step in collagen degradation. Once cleaved, the fragments spontaneously denature at physiological temperature and are then rapidly degraded by gelatinases. MMP-1 (interstitial collagenase) is the primary collagenase in dermal fibroblasts and the most clinically significant for skin ageing. [10]
Gelatinases (MMP-2, MMP-9) degrade denatured collagen (gelatin), basement membrane collagens, and solubilised collagen I and III monomers. [1] They work downstream of the collagenases – completing the degradation of fragments that MMP-1 has already cleaved – and are the primary enzymes degrading the Type IV collagen of the basement membrane at the DEJ.
Stromelysins (MMP-3, MMP-10) degrade basement membrane collagens, proteoglycans, and matrix glycoproteins. [5] MMP-3 is particularly significant because it both degrades structural components directly and activates other MMPs (including MMP-1) amplifying the collagenolytic cascade from a single upstream signal.
Elastases (MMP-12) are the primary elastin-degrading enzymes in skin. MMP-12 (macrophage metalloelastase) degrades functional elastic fibres and simultaneously degrades fibrillin-1, the microfibril scaffold on which new tropoelastin must assemble. This dual substrate specificity means MMP-12 activity both removes existing functional elastin and impairs the assembly of replacement fibres, creating a compounding deficit. [9]
The MMP Substrate Map
| MMP Group | Key Enzymes | Primary Target | Clinical Consequence |
|---|---|---|---|
| Collagenases | MMP-1, 8, 13 | Intact Type I & III Collagen | Thinning dermis; loss of “bounce.” |
| Gelatinases | MMP-2, 9 | Denatured Collagen; Type IV (DEJ) | Compromised DEJ; epidermal sagging. |
| Stromelysins | MMP-3, 10 | Proteoglycans; Activates MMP-1 | Loss of hydration; amplified degradation. |
| Elastases | MMP-12 | Elastin; Fibrillin scaffold | Solar elastosis; permanent skin “creasing.” |
The Endogenous Counter-System: TIMPs
MMP activity in healthy tissue is regulated by tissue inhibitors of metalloproteinases (TIMPs), a family of endogenous proteins that bind to and neutralise active MMPs in a 1:1 ratio. In young, healthy skin. MMP and TIMP activity are balanced such that ECM remodelling proceeds without net structural loss. [9] In aged and photodamaged skin, this balance is disrupted: MMP levels are elevated but TIMP levels do not increase correspondingly, and TIMP-1 levels in photoaged and intrinsically aged skin may even be reduced relative to normal adult skin. The resulting MMP–TIMP imbalance is the direct mechanism of progressive collagen fragmentation accumulation that distinguishes structurally aged dermis from its younger counterpart.
How MMP Activity Is Upregulated in Skin
UV irradiation is the most potent acute driver of MMP upregulation. A single UV exposure activates two independent transcription factor pathways in skin: AP-1 (activator protein-1), activated through reactive oxygen species, drives transcription of MMP-1, MMP-3, and MMP-9; NF-κB activation independently upregulates MMP-1 and MMP-3 in dermal fibroblasts. [6] The scale of induction is substantial. MMP-1 and MMP-3 mRNA levels have been measured at several thousand-fold above baseline at 24 hours post-UV irradiation in human skin in vivo, whilst MMP-9 showed a more modest 6-fold induction. [8] Crucially, UV irradiation induces MMP upregulation in both dermal fibroblasts and epidermal keratinocytes – the two-compartment source distinguishing photoageing from intrinsic ageing, where fibroblasts are the primary MMP source.
Cellular senescence independently elevates MMP production through the SASP. Senescent fibroblasts constitutively upregulate MMP-1, MMP-3, and MMP-9 as part of their pro-inflammatory secretory profile, creating a chronic low-level degradation environment that accelerates with the accumulation of senescent cells in ageing dermis. [9]
Inflammatory cytokines IL-1, TNF-α, and the type 2 cytokines IL-4 and IL-13 activate NF-κB and AP-1 signalling in fibroblasts, driving MMP upregulation through the same transcription factor pathways as UV. This is the mechanism through which chronic skin inflammation, atopic conditions, and systemic inflammatory states accelerate structural dermal ageing independently of UV exposure.
Oestrogen withdrawal at menopause simultaneously reduces oestrogen’s suppression of MMP-1 and MMP-3 in fibroblasts and removes ERβ-mediated collagen synthesis support, shifting the collagen balance in both directions concurrently. The Oestrogen entity describes this dual mechanism in full.
MMP Upregulation Drivers
| Driver | Primary Mechanism | MMPs Induced |
|---|---|---|
| UV (Photoageing) | ROS → AP-1 and NF-κB | MMP-1, 3, 9 (Massive induction) |
| Inflammageing | TNF-α, IL-1, IL-4/13 | MMP-1, 3, 12 |
| Senescence (SASP) | Chronic constitutive secretion | MMP-1, 3, 9 |
| Menopause | Loss of ERβ-mediated suppression | MMP-1, 3 |
The Collagen Fragmentation Feedback Loop
A clinically important consequence of MMP-driven collagen degradation is that it is self-reinforcing. MMP-1 cleaves intact collagen fibrils, producing fragments that accumulate in the dermis. These fragments cannot reassemble into functional fibrils. They occupy space in the ECM whilst providing no structural support, reducing the mechanical tension that fibroblasts detect through mechanoreception. Reduced mechanical tension decreases fibroblast synthetic output – less TGF-β signalling, reduced procollagen transcription – whilst MMP activity continues unabated. The result is a progressively deteriorating structural environment that suppresses the very cellular activity that would be needed to reverse it. [7]
Clinical Application
The clinical framework for MMPs in treatment selection follows a consistent logic across all structural entities: address MMP-driven degradation alongside or before stimulating synthesis, because increasing synthesis into a high-MMP environment accelerates production into a still-unfavourable degradation balance. Treatments that only stimulate collagen production without addressing MMP activity (or that address MMP suppression without stimulating replacement synthesis) each produce partial outcomes.
Treatments That Suppress MMP Activity
Polynucleotides are the most comprehensively MMP-suppressive professional treatment in the Creative Touch portfolio. Their A2AR-mediated macrophage reprogramming drives M2 polarisation and NF-κB inhibition, reducing MMP-1, MMP-3, and MMP-9 simultaneously whilst the downstream TGF-β and IL-10 signal activates fibroblast collagen synthesis. [2] This dual action – degradation suppression and synthesis stimulation through a single mechanism – makes polynucleotides particularly appropriate where MMP-driven degradation is the dominant presentation: significantly photodamaged skin, post-menopausal skin, and chronically inflamed skin where the NF-κB pathway is persistently activated. MMP-12 suppression through the same NF-κB route also protects both functional elastin and the fibrillin scaffold on which replacement elastic fibres depend.
iPRF suppresses MMP-1 expression in UV-irradiated dermal fibroblasts more effectively than PRP, through stronger activation of the TGF-β/Smad signalling pathway and more effective ROS reduction upstream of AP-1 activation. [4] For clients with significant UV-driven MMP upregulation, this makes iPRF’s MMP-suppressive action – alongside its direct synthesis stimulation – particularly relevant. It addresses both the AP-1 transcription factor pathway and the growth factor environment simultaneously.
Vitamin C (L-ascorbic acid) suppresses UV-induced MMP-1 expression in fibroblasts through reduction of ROS-driven AP-1 transcription factor activation; the same upstream pathway that UV irradiation uses to drive MMP-1 and MMP-3 transcription. [5] This is distinct from and additive to vitamin C’s role as a procollagen hydroxylation cofactor – it works at the transcription regulation level whilst the cofactor role works at the maturation level. For clients where UV-driven MMP activity is a persistent concern, topical vitamin C provides continuous between-treatment MMP suppression that professional treatments cannot sustain independently.
Retinoids reduce MMP expression through TGF-β upregulation and direct AP-1 antagonism – retinoid receptor complexes compete with AP-1 for binding at promoter sites, reducing MMP-1 transcription independently of ROS signalling. [3] Long-term retinoid use reduces measurable MMP activity in dermis alongside its collagen synthesis benefits. The two effects are mechanistically coupled through the same TGF-β and AP-1 axes.
HA skin boosters contribute to MMP modulation indirectly through TIMP upregulation: fibroblasts activated through mechanoreception following mid-dermal HA injection show measurable TIMP-1 and TIMP-2 upregulation alongside collagen synthesis increases. This is not direct MMP suppression at the transcription level but restoration of the endogenous counter-system, improving the MMP–TIMP balance from the inhibitor side rather than the enzyme side.
MMP Activity as a Treatment Selection Signal
The MMP subtype profile relevant to a specific client presentation determines the most targeted treatment approach:
- Predominantly collagen-degrading presentation (MMP-1, MMP-3 driven – UV history, chronological ageing): polynucleotides + iPRF + vitamin C + retinoids address the AP-1/NF-κB transcription and synthesis sides simultaneously
- Basement membrane and DEJ degradation (MMP-2, MMP-9 – thinning skin, compromised epidermal–dermal adhesion): thulium laser DEJ remodelling + polynucleotides’ gelatinase suppression through NF-κB
- Solar elastosis presentation (MMP-12 driven – significant photoageing, elastin dysfunction): polynucleotides for MMP-12 suppression via NF-κB + RF microneedling thermal clearance of accumulated elastotic material
- Post-menopausal MMP–TIMP imbalance (oestrogen withdrawal removing MMP suppression): polynucleotides + HA skin boosters address MMP suppression and TIMP restoration from two independent routes
The unifying principle is that in any presentation where net structural loss is occurring, regardless of whether the primary driver is UV, inflammation, senescence, or hormonal withdrawal, MMP activity is the mechanism translating those upstream signals into actual ECM degradation. Addressing the upstream signal without simultaneously addressing MMP activity leaves the degradation pathway intact.
The MMP Clinical Response
| Clinical Goal | Biological Target | Treatment Choice |
|---|---|---|
| Broad Suppression | NF-κB & AP-1 inhibition | Polynucleotides |
| ROS Neutralisation | AP-1 pathway blockage | Vitamin C / iPRF |
| Transcription Control | Retinoid receptor binding | Retinoids (Homecare) |
| Inhibitor Restoration | TIMP-1/2 upregulation | HA Skin Boosters |
References
Laronha H, Caldeira J (2020). Structure and Function of Human Matrix Metalloproteinases. Cells, 9(5) . doi.org/10.3390/cells9051076
Lee KWA, Chan KWL, Lee A, et al. (2024). Polynucleotides in Aesthetic Medicine: A Review of Current Practices and Perceived Effectiveness. Int J Mol Sci, 25(15) . doi.org/10.3390/ijms25158224
Lee YI, Lee SG, Jung I, et al. (2023). Topical Application of Peptide Nucleic Acid Antisense Oligonucleotide for MMP-1 and Its Potential Anti-Aging Properties. J Clin Med, 12(7) . doi.org/10.3390/jcm12072472
Li Y, Song P, He J, et al. (2022). Comparison Between Injectable Platelet-rich Fibrin and Platelet-rich Plasma in Ameliorating UVA-induced Photoaging in Human Dermal Fibroblasts via the Activation of TGF-β/Smad Signaling Pathway. Photochem Photobiol, 98(6), 1395-1401 . doi.org/10.1111/php.13628
Philips N, Auler S, Hugo R, et al. (2011). Beneficial regulation of matrix metalloproteinases for skin health. Enzyme Res, 2011, 427285 . doi.org/10.4061/2011/427285
Pittayapruek P, Meephansan J, Prapapan O, et al. (2016). Role of Matrix Metalloproteinases in Photoaging and Photocarcinogenesis. Int J Mol Sci, 17(6) . doi.org/10.3390/ijms17060868
Quan T, Little E, Quan H, et al. (2013). Elevated matrix metalloproteinases and collagen fragmentation in photodamaged human skin: impact of altered extracellular matrix microenvironment on dermal fibroblast function. J Invest Dermatol, 133(5), 1362-6 . doi.org/10.1038/jid.2012.509
Quan T, Qin Z, Xia W, et al. (2009). Matrix-degrading metalloproteinases in photoaging. J Investig Dermatol Symp Proc, 14(1), 20-4 . doi.org/10.1038/jidsymp.2009.8
Shin JW, Kwon SH, Choi JY, et al. (2019). Molecular Mechanisms of Dermal Aging and Antiaging Approaches. Int J Mol Sci, 20(9) . doi.org/10.3390/ijms20092126
Van Doren SR (2015). Matrix metalloproteinase interactions with collagen and elastin. Matrix Biol, 44-46, 224-31 . doi.org/10.1016/j.matbio.2015.01.005
Also Known As
- matrix metallopeptidase
- matrix metalloproteinases
- matrixin
- matrixins
- MMP
- MMPs
Biological Relationships
Biological Interactions
- Inhibits Collagen
- Inhibits Elastin
- Inhibits Heparan sulfate proteoglycans Evidence: MMP activity degrades HSPG core proteins depleting ECM growth factor reservoir; MMP-overactive skin progressively depletes HSPG-bound VEGF. PMC4046116.
- Inhibits Hyaluronic acid
- Inhibits Platelet-derived growth factor Evidence: MMP-degraded ECM provides less permissive substrate for PDGF-driven fibroblast migration via PDGFR-beta; fragmented matrix reduces PDGF recruitment yield. Li et al. 2003 DOI 10.1091/mbc.e03-05-0352.
- Affects Psoriasis Evidence: MMPs elevated in psoriatic lesions contribute to dermal ECM remodelling; TNF-driven MMP induction central to psoriatic pathology. Entity text; PMC10815999.
- Affects Rosacea Evidence: MMP-9 further processes KLK5 into its active form, amplifying the KLK5→LL-37 signal; a key step in the rosacea self-amplifying loop.
- Affects Skin ageing Evidence: UV-driven AP-1 upregulates MMP-1, MMP-3, MMP-9; MMP-1 cleaves fibrillar Type I and III collagen; chronic fragmentation accumulation compounds progressive synthesis suppression to produce photoaged dermis (PMC2909639).
- Affects Skin barrier dysfunction Evidence: MMP-2 and MMP-9 degrade type IV collagen at the DEJ compromising epidermal-dermal junction integrity and contributing to skin barrier dysfunction. Entity text; Laronha & Caldeira 2020.
Influenced By
- this Stimulated by Adipocyte Evidence: Senescent adipocytes secrete MMPs (MMP-3, MMP-12) as SASP, degrading ECM in adipose and overlying dermis. Entity text; PMC9616990.
- this Stimulated by Cortisol Evidence: Cortisol activates glucocorticoid receptor leading to MMP pathway upregulation and ECM suppression in skin. Choo 2023 cimb45010025; Robiolo 2024 PMC11743297.
- this Stimulated by Interleukin-13 Evidence: IL-13 (type 2 cytokine) activates NF-kB and AP-1 in fibroblasts driving MMP upregulation. Entity text; PMC3057026.
- this Stimulated by Interleukin-4 Evidence: IL-4 (type 2 cytokine) activates NF-kB and AP-1 in fibroblasts driving MMP upregulation. Entity text; Laronha & Caldeira 2020 cells9051076.
- this Stimulated by Interleukin-6 Evidence: IL-6 activates STAT3/NF-kB in fibroblasts stimulating MMP-1 and MMP-3 expression; hypoxic MSC treatment suppresses IL-6 and MMP-3 in UVB-damaged skin. Anindyasarathi 2025 DOI 10.5937/scriptamed56-57508.
- this Stimulated by Oestrogen decline Evidence: Oestrogen withdrawal upregulates MMP-1 and MMP-3 in dermal fibroblasts, accelerating collagen and elastin degradation; dual effect (reduced synthesis + increased degradation). PMC12374573; PMC10991793.
- this Stimulated by Tumour necrosis factor Evidence: TNF-alpha activates NF-kB and AP-1 in dermal fibroblasts driving MMP-1/3/9 upregulation. Entity text; Radtke et al. 2019 PMC6829232.
- this Inhibited by Niacinamide Evidence: Niacinamide inhibits NF-kB activation and suppresses MMP-1 expression in UV-irradiated skin cells. Bissett et al. 2004 Int J Cosmet Sci.
- this Inhibited by Oestrogen
- this Inhibited by Polynucleotides
- this Inhibited by Retinoid Evidence: Retinoids reduce MMP expression via TGF-beta upregulation and direct AP-1 antagonism at promoter sites. Entity text; PMC10095221.
- this Inhibited by Transforming growth factor beta Evidence: TGF-beta1 stimulates TIMP-1/TIMP-2 expression suppressing MMP activity; iPRF TGF-beta activation produces greater MMP-1 suppression; canonical anti-degradation function of TGF-beta/Smad pathway (PMC5831781; Wiley doi:10.1111/php.13628).
- this Inhibited by Vitamin C Evidence: Vitamin C suppresses UV-induced MMP-1 expression via reduction of ROS-driven AP-1 transcription factor activation. Entity text; PMC3057026.
- this Produced by Cellular senescence Evidence: Senescent dermal fibroblasts produce a SASP weighted toward MMP-1, MMP-3, and IL-6.
- this Produced by Fibroblast Evidence: Senescent fibroblasts… actively upregulate MMP-1, MMP-3, and MMP-9, contributing to collagen and elastin degradation
- this Produced by Senescence-associated secretory phenotype Evidence: SASP: senescent fibroblasts constitutively upregulate MMP-1, MMP-3, MMP-9 as part of pro-inflammatory secretory profile creating chronic degradation environment. Entity text; PMC6540032.
Learn More
This topic is discussed in 3 articles:
-
If you can’t stop thinking about food, it might not be addiction. Discover why chronic dieting and restriction create a biological backlash, and how to fix it.
-
-
Zinc-dependent endopeptidases involved in extracellular matrix remodelling during barrier repair; dysregulated MMP activity can degrade collagen and delay structural restoration of the dermis.